Collaboration paves the way for highly cited titles in biochemistry and molecular biology to transition to gold open access
NEW YORK, May 12, 2020 /PRNewswire/ -- The American Society for Biochemistry and Molecular Biology (ASBMB) and Elsevier, a global information analytics business specializing in science and health, are delighted to announce a new partnership to publish the ASBMB's Journal of Biological Chemistry (JBC), Molecular & Cellular Proteomics (MCP) and Journal of Lipid Research (JLR). As part of this agreement, all three titles will move to a gold open access (OA) publishing model, making articles immediately and permanently available for everyone to read, download, copy and distribute. The journals will be hosted on Elsevier's leading online platform, ScienceDirect, beginning January 1, 2021.
The ASBMB advances the mechanistic understanding of nature through promotion of the highest-quality research in biochemistry and molecular biology. The society's decision to partner with Elsevier to transition its journals from a hybrid subscription model to gold OA is a reflection of its commitment to make the high-quality papers that the journals publish immediately and permanently available to the public.
"ASBMB journals have earned a strong reputation for publishing papers based on the quality of the science and their contributions to advancing a field. The practicing scientists who lead and review for our journals will continue to make all editorial decisions," says ASBMB President Gerald Hart, Professor and Georgia Research Alliance Eminent Scholar at the University of Georgia. "Authors can count on ASBMB journals to continue providing rigorous, fast and fair peer review."
Elsevier's experience transitioning journals to gold open access was a key factor in their selection.
"We believe open science can bring meaningful benefits to society by enhancing research performance, so we are delighted to partner with the ASBMB to transition these highly-cited journals to gold open access. By working together, we can achieve a more inclusive, collaborative and transparent world of research," said Elsevier CEO Kumsal Bayazit.
Founded in 1906, the ASBMB has a long, rich history of supporting researchers throughout their careers. "I happen to be one of those scientists who benefited directly from ASBMB's educational resources at conferences early in my career," said Hélène Hodak, Publisher at Elsevier. "The ASBMB invested in generations of scientists over the years, and now they are part of academia, healthcare and various industries, including publishing. It is a thrill to be able to support the society in this transition and, in the process, support future generations of scientists."
"This partnership is going to benefit authors in several ways. It will streamline the submission process, make authors' research discoverable on the ScienceDirect platform, in addition to our own journals' websites, and, importantly, lower the cost of open-access publishing in ASBMB journals for both members and non-members," said Nancy Rodnan, Senior Director of Publications for the society.
The American Society for Biochemistry and Molecular Biology is an international non-profit scientific and educational organization. With more than 11,000 members, made up of students, researchers, educators and industry professionals, the ASBMB is one of the largest molecular life science societies in the world.
Founded in 1906, the ASBMB's mission is to advance the science of biochemistry and molecular biology and to promote the understanding of the molecular nature of life processes. The society serves the scientific community through:
- Publication of peer-reviewed journals and science news.
- Organization of scientific meetings.
- Advocacy for funding of basic research and education.
- Support of career development and science education at all levels.
- Promoting the diversity of individuals entering the scientific workforce.
About Elsevier and society partnerships
Elsevier has long partnership records with over 600 learned scientific societies and works with organizations worldwide to support them in their mission of education support of the scientific communities. This includes support for global open science such as the partnership with Next Einstein Forum to launch the pan-African open access journal Scientific African. www.elsevier.com/books-and-journals/societies.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com